Correlation Between Sino Biopharmaceutica and Silo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sino Biopharmaceutica and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sino Biopharmaceutica and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sino Biopharmaceutical Limited and Silo Pharma, you can compare the effects of market volatilities on Sino Biopharmaceutica and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sino Biopharmaceutica with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sino Biopharmaceutica and Silo Pharma.

Diversification Opportunities for Sino Biopharmaceutica and Silo Pharma

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Sino and Silo is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Sino Biopharmaceutical Limited and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Sino Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sino Biopharmaceutical Limited are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Sino Biopharmaceutica i.e., Sino Biopharmaceutica and Silo Pharma go up and down completely randomly.

Pair Corralation between Sino Biopharmaceutica and Silo Pharma

Assuming the 90 days horizon Sino Biopharmaceutical Limited is expected to generate 0.52 times more return on investment than Silo Pharma. However, Sino Biopharmaceutical Limited is 1.92 times less risky than Silo Pharma. It trades about 0.08 of its potential returns per unit of risk. Silo Pharma is currently generating about -0.07 per unit of risk. If you would invest  38.00  in Sino Biopharmaceutical Limited on August 30, 2024 and sell it today you would earn a total of  4.00  from holding Sino Biopharmaceutical Limited or generate 10.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sino Biopharmaceutical Limited  vs.  Silo Pharma

 Performance 
       Timeline  
Sino Biopharmaceutical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sino Biopharmaceutical Limited are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating technical and fundamental indicators, Sino Biopharmaceutica may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Silo Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Sino Biopharmaceutica and Silo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sino Biopharmaceutica and Silo Pharma

The main advantage of trading using opposite Sino Biopharmaceutica and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sino Biopharmaceutica position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.
The idea behind Sino Biopharmaceutical Limited and Silo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings